We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
COO, mOm Incubators Ltd
Cost-effective, electronically controlled, inflatable incubators, developed by mOm, could help to improve the survival rates of prematurely born babies.
The World Health Organization estimates that there are 15 million premature births each year and highlights that preterm birth complications are the leading cause of deaths in children under the age of five, responsible for one million deaths in 2015. Three-quarters of these deaths are said to be preventable with current, cost-effective solutions. Compact, robust inflatable incubators, created by mOm can provide an accessible solution in places that need it.
The incubators have been designed in close collaboration with clinical specialists to ensure that it is both user-friendly and meets clinical quality standards.
Chief Operating Officer and co-founder, Matthew Khoory, has a significant role in leading strategy and business development as the company finalises development and testing of its product. This includes conducting clinical trials to gather the data needed for regulatory approval.
Using training from the SME Leaders Programme, Matthew will develop skills for managing a team that is growing significantly. Mentoring and coaching through the programme will help as Matthew strengthens skills in negotiation and project management to create and foster the partnerships that will support the company’s continued growth.
Visit mOm Incubator's website here.
Tracking items in shops, hospitals, factories and warehouses can be difficult. Using radio-frequency identification (RFID) to detect and track passive (battery-free) tags placed on objects can be problematic - hand-held readers can take a very long time, but static/fixed readers often have dead spots and detection accuracy can be as low as 80%.
Dr Sithamparanathan Sabesan is the CEO and Co-Founder of PervasID. PervasID provide the most accurate passive RFID technology available using its patented, ground-breaking innovation. Using advanced signal processing techniques to overcome dead spot challenges, its technology can achieve a detection accuracy of more than 99% over an area of 400m² with a single reader and unlimited coverage with multiple readers. This has enabled the company to establish fixed readers, often in the ceiling, that capture the progress of a passive tag from the moment it enters a building to when it leaves. This ability to pinpoint items, even when they are tightly packed, has led to inward investment for the company of over £4.5 million.
PervasID’s technology is already used in industrial locations to enable tool-tracking in mission-critical applications and in hospitals to track medical devices, PPE and patient flow. In warehouses, shops and factories it provides a record of items from portal to checkout and has additional uses in logistics and supply chain settings.
“The SME Leaders programme provided leadership training that has enhanced my business skills and enabled me to take the company to the next level. We are no longer a startup, we are now a scale-up company. Over the next two years we plan to scale up our business while expanding our innovation and technology.”
Chief Operating Officer at Notpla Ltd
Around 50% of plastic packaging is used once and thrown away, but it takes hundreds of years to decompose. Notpla Ltd has created a plastic alternative, made from plants and brown seaweed, that biodegrades naturally in four to six weeks. Seaweed is an ideal base material to work with as it grows rapidly and does not compete with food crops for land or freshwater.
The company’s first product, Ooho, is a flexible biodegradable packaging for beverages and sauces that can also be eaten. Ideal for products with a short-use life, Oohos can replace plastic cups and bottles for running events and other sporting occasions.
Notpla’s second product is a coating for paperboard. Lined cardboard is usually coated with plastic made from oil or corn, both of which are non sustainable. Now on sale to restaurants via Just Eat, the boxes are designed for the food takeaway industry to be both waterproof and greaseproof, are biodegradable and can even be repulped.
Lise Honsinger is Notpla’s Chief Operating Officer, leading its transition from development to commercial operations. Lise has a fast-growing team and became an SME Leader in 2019. She is using the programme’s mentoring and coaching to help the company establish operational structures and a culture that promotes growth.
The company is now expanding into other applications, including sachets that can hold dry goods, shampoos and cosmetics. Small sachets are an area of packaging that has been difficult to replace in the past as they usually are made from layered plastics and aluminium and aren’t recyclable. Notpla is working with Just Eat and Unilever to test out these and other possible future uses for its biodegradable material.
CEO, Odin Vision
Odin Vision has developed a novel artificial intelligence (AI) technology for endoscopy to help support doctors in detecting and diagnosing cancer.
Patients showing signs of bowel cancer may have a colonoscopy with a small endoscopic camera to inspect tissue for small growths, called polyps, some of which can develop into cancer. These can be challenging for clinicians to detect and diagnose with some studies suggesting that over 20% of polyps can be missed.
Founded by a team of clinicians, medical imaging and AI experts, Odin Vision has developed a suite of tools that use AI to improve detection and diagnosis. The technology uses deep-learning algorithms to identify polyps in real-time so that doctors can more efficiently make diagnoses at the earliest stage possible. This improves patient outcomes by increasing opportunities for early treatment to reduce the incidence and impact of bowel cancer.
Peter Mountney, CEO, is developing a strategy to support Odin Vision through clinical trials and obtaining regulatory approval. Peter aims to use a combination of training, mentoring and coaching through the SME Leaders Programme to get timely support in financing and change management at a time of significant growth.
Visit Odin Vision's website here.
Many young children want to engage with and create music but can find it difficult to learn an instrument.
Coming from a musical family, Michael developed the technology to support children to enjoy and be creative with music. He felt that the challenge of getting sounds out of an unfamiliar instrument gets in the way of understanding how notes fit together to make music.
Michael’s solution uses ‘Bops’ - brightly coloured blocks that each play different musical notes when arranged on a board. The Bops can switch between different instrument sounds and be endlessly rearranged to create new tunes and even combined into chords when stacked together.
Designed for children aged three to six years old, Soundbops makes it easy and fun for children to create their own music, discovering as they go what works and what doesn’t.
The technology’s ease-of-use encourages creativity and experimentation. It has strong educational value as it engages children in reading sheet music and composing songs without having to first master a complex musical instrument.
Michael plans to work with toy manufacturers and schools to capture a share of the £45 billion global educational technology market. In February 2018, Michael ran a successful crowdfunding campaign, raising over £50,000 to start manufacturing Soundbops.
Michael was the winner of the Hub’s 2016 Launchpad Competition and received the JC Gammon Award – a prize of £15,000 and Membership of the Hub.
CEO, Agile Analog
Established in 2017, Agile Analog is rapidly transforming the semiconductor market through its automation of the design and delivery processes of analog intellectual property (IP) for microchips.
Before, chip designers had to use a limited range of one-size-fits-all analog IP products. Now, Agile Analog enables system-on-chip and application-specific integrated circuit manufacturers to configure bespoke analog IP to fit their application and silicon processes. This customisation has helped disrupt the semiconductor market and in 2021 led to a successful funding round of more than £13 million for the company.
Tim Ramsdale is the CEO of Agile Analog. Tim became an SME Leader in 2019 and says: “The programme has provided me with an excellent business coach who has helped me overcome some tricky commercial events while growing the company. I’ve found the courses useful too, especially those covering sales and strategic product development.”
Agile Analog is now looking to rapidly expand its workforce by growing its commercial and engineering support teams servicing the UK, North America and Asian markets. It has also created a number of industry partnerships that focus on different technologies and innovations. One example is a new product that secures digital circuitry, preventing hackers bypassing security protection common on IoT (internet of things) products.
Visit Agile Analog's website here.
CEO of Kinomica Ltd
On average, it takes 15 years to develop new drugs and can cost more than £2 billion from discovery to launch. Once launched, drugs can be hindered by not matching the right compound to the right patient at the right time. Precision medicine offers an alternative model by developing medicines that are personalised to the patient. It focuses on a deep, molecular knowledge of a particular person’s disease. This approach offers huge benefits not just to patients but healthcare bodies, as well as pharmaceutical and diagnostic industries.
Kinomica has a bioinformatics platform called KScan® that generates insights into the activities of the cell’s proteins and their complex signalling cascades, especially in cancer. KScan uses a database, patented algorithms and a protein activity ranking method to analyse diseased tissue and identify the best match of drug for each patient. This KScan approach offers a ‘hypothesis-free’ way of looking at which cell signalling mechanisms are driving diseases and how best to treat them.
Jane Theaker is the CEO of Kinomica Ltd. Jane is responsible for providing the company’s mission, raising finance to support its commercial aims and overall leadership. She joined the Scale Up Accelerator programme in 2021 and hopes it will provide her with additional leadership skills that will help grow the company from Series A to Series B funding, and eventually to a trade sale or stock market issue.
Kinomica’s KScan platform and world-leading expertise in cell signalling can develop better drugs and diagnostic tests. Jane says: “At Kinomica, we are completely focused on saving patients’ lives, by getting this disruptive technology to the bedside as quickly as we can.”
For updates from Kinomica Ltd, you can follow their Twitter channel here.
Plural AI is creating a new way to navigate industries by building a rich map of the world’s corporate landscape. Using natural language processing and machine learning, it mines and links web data such as websites, filings and news sources to create an understanding of what companies do, their ecosystems and how well they are performing. Clients can access Plural AI’s proprietary knowledge graph to gain bespoke financial insights and analysis.
Camille Rougié is Co-Founder and CEO of Plural AI. Camille joined the SME Leaders programme in 2020. She says: “I am looking forward to the one-to-one mentoring and coaching. I am also very excited to meet the other participants in the programme. In my experience, peer mentoring and support has always been one of the best ways to learn the tricks of the trade.”
Plural AI’s knowledge engine is readily scalable. It can deploy systems across the internet to apply additional metrics and filters. The company can also build predictive models to help make informed financial decisions. In the coming years, Camille says that the focus will be on building up the company’s profile and brand as well as accelerating its growth and expansion.
Co-Founder and Chief Operating Officer, Arctoris Ltd
Founded in 2016, Arctoris Ltd has developed the world’s first fully automated, robotic laboratory for drug discovery. Ulysses, its fully automated drug discovery platform, uses advanced cellular and molecular biology techniques to validate new ideas for drug discovery programmes.
The platform brings together robotics, artificial intelligence (AI) and blockchain to generate drug discovery milestones including target identification, candidate characterisation and dataset generation for AI model validation. Arctoris’s pairing of computational techniques with wet-lab automation reduces cycle times, decreases attrition rates and makes drug discovery success more likely.
Tom Fleming, a chemical biologist, is the Co-Founder and Chief Operating Officer of Arctoris. Tom is responsible for overseeing the company’s team, technologies and expansion. He became an SME Leader in 2019 and has used support from the programme to help scale up the company and deliver drug discovery successes. For his work in the life sciences, he has been recognised by the European Laboratory Research & Innovation Group with the inaugural ECP Impact Award.
Arctoris now has its own drug discovery pipeline as well as creating partnerships with other biotech, pharma and AI companies to develop their work. Its patented proprietary technologies have led to joint ventures with AI companies and research contracts with biotech and pharma on three continents, enabling them to bring new medicines to patients much faster.
Visit Arctoris's website here.
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
Formerly the UK Innovation Director for Atkins, Elspeth is the CEO and Founder of IAND, a digital platform that helps major enterprises manage multiple suppliers.
Initially graduating as a chemist, Elspeth later turned her hand to transport and urban design, demonstrating business and technical leadership on over 100 transport planning projects both nationally and around the world.
Elspeth chairs the Enterprise Hub’s Innovators Network and is a judge for the Hub’s Launchpad Competition. She is also a member of the Royal Academy of Engineering’s Diversity and Inclusion Committee.
In 2017, Elspeth was awarded a Member of the Order of the British Empire (MBE) for her services to Engineering and Enterprise.
“I believe that collaboration within our industry is the key to driving innovation faster. I am so proud to be involved with the Enterprise Hub, as a Mentor, and as Chair of the Innovators Network and to support young entrepreneurs as a Judge on Launchpad competition.
It is rare to find a place which brings together startups and established companies to exchange ideas and learn from each other. We have a shared goal which is to fast track the growth of engineering enterprises in the UK. The Enterprise Hub has helped me grow my business and it is helping young engineers build the businesses of the future.”
Paul Excell is an award-winning entrepreneur, investor and global executive leader with an impressive track record of delivering growth and transformation in startups, scale-ups, global corporates and is passionate about social mobility. He is Chief Operating Officer and Non-Executive Director at ScaleUp Group™️, providing tech scaleups with unique insights from successful entrepreneurs with over $4 billion in exits plus patient equity/debt growth funding (£2 million to £20 million). He has six tech clients in the growth portfolio, and his clients have raised £30 million to date.
In addition to this, Paul is Co-Founder and Chair of Global iLabs, Founder and CEO of Excelerate™️ and Non-Executive Director with Knowledge Gateway (University of Essex). He acts as a judge and mentor for the UK Enterprise Awards and the Royal Academy of Engineering’s Launchpad Innovation Award and SME Leaders.
Paul was previously Chief Customer Innovation Officer, Chief Operating Officer/Group Technology Officer, SVP[PS1] Global at BT, Chair/member of several business Boards (UK and Spain, Nordics, AsiaPac) and sat on BT Group Board committees on Technology, Risk and Diversity. He was an Engineering Council Board member and acted as advisor to UN Secretary General on sustainability, technology and innovation.
He started his career as an apprentice and is now a chartered engineer (CEng), Fellow of the Institution of Engineering and Technology (FIET), the Chartered Institute for IT (FBCS) and Court Liveryman, Worshipful Company of Information Technologists.
Professor Mark Arthur Tooley FREng is the immediate Past President of the Institute of Physics and Engineering in Medicine. He was the Head of the Department of Medical Physics and Bioengineering and Director of Research and Development at the Royal United Hospitals, Bath until 2017 when he retired from full-time NHS work. Since then, he has held several part-time roles. He is a specialist scientific advisor for NHS England, a digital clinical advisor for the West of England Academic Health Science network, and a healthcare technology consultant. He is a registered Consultant Clinical Scientist, an honorary professor at the University of Bath, and a visiting professor at the University of the West of England.
Mark completed his BSc in Electrical and Electronic Engineering at the University of Bath in 1979. He was sponsored by Westinghouse Brake and Signal company for the four years of the course. He then did an MSc and PhD in Medical Physics at the University of London. His MSc thesis was developing a EEG frequency analyser for anaesthesia. For his PhD research, Mark invented (with a cardiologist) an original method for rate-independent diagnosis of cardiac rhythm for implantable devices, which was patented. He spent the rest of his career in Medical Physics and Bioengineering departments, both in hospitals and academia, working along medical colleagues. He has worked at St Bartholomew’s hospital in London, Bristol University, United Bristol healthcare NHS Trust, and the Royal United Hospital, Bath. He is a Fellow of the Royal Academy of Engineering, the Royal College of Physicians, the Institute of Engineering and Technology, the Institute of Physics and Engineering in Medicine, and the Institute of Physics. He is a chartered engineer and chartered scientist. Mark is on the peer-review college of EPSRC, has recently been a member of the Engineering and Physical Sciences Research Council Healthcare Technologies Strategic Advisory Team and the Royal Society Fellowship panel.
Mark has been a long-standing member of the Panel for Biomedical Engineering at the Royal Academy of Engineering (now called the healthcare policy topic group). He was recently a member of the biomedical engineering membership panel, the Policy Committee, and the working group for Systems thinking in healthcare. He has mentored on the enterprise scheme.
Mark’s research interests include innovations in medicine, physics applications in anaesthesia, simulation in medicine, physiological measurement, biological signal processing, measuring the depth of anaesthesia, blood pressure measurement and novel patient monitoring solutions.
As an entrepreneur and communications professional, Helen's mission is to help businesses do more good in the world. After nearly 15 years working in government relations and leadership communications, Helen set up her own boutique communications agency, HN Communications. A smaller and more person-centred alternative to bigger agencies, HN Communications works with large and small clients to deliver complex communications projects. Clients include Bosch, Heineken, Nissan and The Climate Group.
Helen founded her latest venture, Leaders LIVE in 2020, just as COVID-19 hit. Leaders LIVE fills a much-needed gap in the market for an independent, online platform for thought leadership and debate. Leaders LIVE brings together leaders from business, government and NGOs to debate some of the biggest challenges facing our world today, from tackling climate change to addressing diversity. After only a year Leaders LIVE has built a dedicated community, with live events hosted on LinkedIn and YouTube. Events regularly have hundreds of live attendees, with thousands more catching up on the replay.
With a mechanical engineering degree from Imperial College London and an MBA from Erasmus, Mike is a chartered engineer, a Fellow of the Institution of Mechanical Engineers and a Sainsbury Management Fellow.
He has led turnarounds, helped establish new businesses and delivered complex projects; challenging and coaching teams to innovate and transcend existing performance. Mike’s experience includes senior operations, project and corporate roles with Royal Dutch Shell UK, and large-scale project development and delivery roles at Alstom in locations across Europe, Asia and North America. Most recently he has been a Director at Centrica Energy, where he is responsible for one of the company’s largest operated gas businesses. He is a Non-Executive Director of Acqualithium and Vice-Chair of the Board of Hymers College.
Naomi started her career at the National Criminal Intelligence Service (now the National Crime Agency), where she spent three years looking at fraud and financial crime intelligence. It included a stint working with the FBI in Quantico, Virginia. She then moved to RBS, where she spent 10 years working in various risk roles, across both the first and second line of defence.
Most recently, Naomi has been working at LBG as a Director in the Chief Resilience and Security Office, where she led on operational resilience and cyber and information security policy. She co-founded the Operational Resilience Collaboration Group, made up of more than 40 firms working together to build resilience in the industry, and co-authored the ORCG industry standard on operational resilience. Naomi also developed the ‘Mind the Gap’ initiative across various FTSE100 companies, with senior women giving inspirational talks and providing mentorships to help encourage more women into careers in security.
Dr John C Taylor OBE FREng was born in Buxton, Derbyshire in 1936. Having spent five years living in Canada
during his childhood, he returned home towards the end of the Second World War.
He attended King William’s College on
the Isle of Man before studying Natural Sciences at the University of Cambridge.
Dr John C Taylor is one of the UK’s most successful and prolific living inventors and, over a sixty-year career, has invented, produced and sold components for numerous electrical appliances around the world.
While at his company Strix Ltd, Dr Taylor established the business as the world-leading manufacturer of kettle controls. His research was instrumental in designing the ubiquitous safety switch that turns a kettle off when it boils and prevents it from overheating, and he also designed the 360˚ cordless connectors in modern kettles.
Dr Taylor’s innovations led to the production and sale of almost two billion kettle controls - 75% of the global market. His inventions in the development of bi-metallic safety critical cut-outs for electric motors are also used in domestic appliances such as hairdryers and fan heaters. His work has also seen over four hundred patents filed, including automatic windshield wipers, electric motor protectors and cordless kettle connectors and controls, and it is a testament to these components’ visionary design that they continue to be in prolific use today.
Dr Taylor has been the recipient of many honours including, but not limited to, the following:
He is also an elected Honorary Fellow of Corpus Christi College, University of Cambridge, and has been conferred Honorary Doctorates from University of Manchester Institute of Science and Technology (UMIST) and Durham University. When he’s not inventing and innovating, Dr Taylor is a keen aviator, mountaineer, yachtmaster and philanthropist.
Dr John C Taylor is a committed philanthropist and has made a number of donations in order to ensure that young engineers in the UK have the tools they need to be competitive in a global market. In 2017, he became the main sponsor of the new Dr John C Taylor Enterprise Hub, affectionately known as the Taylor Centre, in the Royal Academy of Engineering. He also established in perpetuity a Chair Professorship of Innovation in the Engineering Department of the University of Cambridge.
Following his career in creating electrical control switches, Dr Taylor became well-known for his interest in clocks and is one of the world’s leading experts in the work of John Harrison, an early pioneer of timekeeping and sea clocks. This led him to design and help build the Corpus Chronophage, a large, time-eating clock which that stands proud on the exterior of the Taylor Library, Corpus Christi College, Cambridge. Dr Taylor donated the clock, alongside a bestowment to make the Taylor Library possible, to his alma mater in order to support bright students of future generations.
Richard has significant experience in managing early stage and high-growth investor-backed businesses. He has spent the last 20 years finding, building and exiting these, investing in many.
He has a strong focus on numbers, financial models, strategic and execution planning, and risk management. He has a toolkit of methodologies to call on to help businesses grow.
He is an experienced non-executive director of both SME and PLC (AIM) companies, has a good knowledge of the funding landscape and is well networked (UK and global) with connections to most Venture Capital, PE, lawyer, accountant and High Net Worth Investor communities. He has led and advised on many fundraises, including: grant; EIS and SEIS High Net Worth Investors; Venture Capital Trust; crowdfunding; ‘follow-ons’; Series A; ‘new’ such as, revenue-based funding; and all forms of debt.
Richard is a trained mentor and coach and able to challenge and win trust at the same time. He has designed and delivered incubator and accelerator structures and programmes.
He founded and runs Realise Capital, a strategic financial and growth practice, is a chartered accountant (FCA) and previously has had roles as co-founder, CEO and corporate finance director. He has seen and had to deal with most situations that arise on a growth journey and can be hands on if the need arises. He has supported more than 75 ambitious founders to achieve exits in excess of £150 million and raise investment in excess of £25 million.
Amelia is a Senior Growth Architect at BCG Digital Ventures. She has more than five years’ experience building and scaling numerous B2B and B2C tech startups in the UK, US, Dubai and France. She has also worked with some of the world’s largest corporates to accelerate their marketing, sales and e-commerce efforts.
Her capabilities include competitive market intelligence, data-driven marketing experiments, analytics, go-to-market strategies, proposition development, digital marketing, and creating martech stacks across traditional and digital channels. Prior to BCG Digital Ventures, Amelia was a Growth Strategy Consultant at Manifesto Growth and Head of Brand and Partnerships at TRIBE.